Mid-Morning Market Update: Markets Mostly Higher; Fibrocell Receives Cash Bid From Castle Creek Pharma


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Following the market opening Friday, the Dow traded up 0.28% to 27,259.71 while the NASDAQ fell 0.02% to 8,193.06. The S&P also rose, gaining 0.17% to 3,014.70.


Leading and Lagging Sectors

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Materials shares climbed 0.6% on Friday. Meanwhile, top gainers in the sector included Taseko Mines Limited (NYSE:TGB), up 7%, and Ferroglobe PLC (NYSE:GSM), up 4%.

In trading on Friday, information technology shares fell 0.7%.


Top Headline

Castle Creek Pharmaceutical Holdings announced it will acquire Fibrocell Science, Inc. (NASDAQ:FCSC), a cell and gene therapy company in a $3 per share cash.

Castle Creek Pharmaceuticals is a privately held company developing therapies for patients with rare, serious or debilitating dermatologic conditions. Castle Creek Pharmaceuticals already has a licensing and development collaboration with Fibrocell, which began in April.
.



Equities Trading UP

MER Telemanagement Solutions Ltd. (NASDAQ:MTSL) shares shot up 60% to $1.92 after reporting half-year results. Mer Telemanagement reported H1'19 EPS of $(0.04) on sales of $2.6 million.

Shares of Fibrocell Science Inc (NASDAQ:FCSC) got a boost, shooting up 60% to $2.94 after the company agreed to be acquired by Castle Creek Pharmaceutical for an all-cash consideration of $3 per share.

Vince Holding Corp. (NYSE:VNCE) shares were also up, gaining 20% to $13.82 after the company reported Q2 results.


Equities Trading DOWN

Ardelyx, Inc. (NASDAQ:ARDX) shares tumbled 14% to $5.40. Ardelyx announced the FDA has approved its tenapanor, brand name Ibsrela, a 50mg twice-daily oral pill for the treatment of irritable bowel syndrome with constipation in adults. The drug acts locally in the gastrointestinal tract by inhibiting the sodium-hydrogen exchanger, leading to increased bowel movements and decreased abdominal pain.

Shares of Park City Group, Inc. (NASDAQ:PCYG) were down 16% to $6.45 after reporting Q4 results.


FREE REPORT: How To Learn Options Trading Fast

In this special report, you will learn the four best strategies for trading options, how to stay safe as a complete beginner, ​a 411% trade case study, PLUS how to access two new potential winning options trades starting today.Claim Your Free Report Here.


Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) was down, falling 70% to $0.3283 following a clinical readout. Ritter said the Phase 3 trial of RP-G28 that's being evaluated for lactose intolerance failed to show statistical significance in its pre-specified primary endpoint..


Commodities


In commodity news, oil traded up 0.4% to $55.30, while gold traded up 0.5% to $1,514.70.

Silver traded up 0.2% Friday to $18.21, while copper rose 1.5% to $2.679.

Euro zone


European shares were higher today. The eurozone’s STOXX 600 rose 0.2%, the Spanish Ibex Index rose 0.5%, while Italy’s FTSE MIB Index rose 0.6%. Meanwhile, the German DAX rose 0.5% and the French CAC 40 climbed 0.3% while UK shares rose 0.1%.

Economics

The import price index dropped 0.5% for August, while export prices declined 0.6% last month.

U.S. retail sales increased 0.4% for August, versus economists’ expectations for a 0.2% rise.

The University of Michigan's consumer sentiment index rose to 92 in September, versus 89.8 in previous month.

U.S. business inventories rose 0.4% for July, versus economists’ expectations for a 0.3% gain.

The Baker Hughes North American rig count report for the latest week is schedule for release at 1:00 p.m. ET.


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Posted In: EarningsNewsEurozoneCommoditiesGlobalIntraday UpdateMarketsMid-Morning Market Update